AMY SCHORN: Open Payments
NPI 1457583189 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,292 in 39 payments from 20 companies in 2025. Trend: 2023 $1,982 · 2024 $529 · 2025 $1,292
Food & beverage: $1,139Education: $153
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $216 |
| SEAGEN INC. | 2 | $153 |
| E.R. Squibb & Sons, L.L.C. | 2 | $137 |
| AstraZeneca Pharmaceuticals LP | 1 | $120 |
| GlaxoSmithKline, LLC. | 4 | $95 |
| Daiichi Sankyo Inc. | 3 | $77 |
| Janssen Biotech, Inc. | 3 | $76 |
| Sumitomo Pharma America, Inc. | 1 | $60 |
| PFIZER INC. | 2 | $57 |
| Novartis Pharmaceuticals Corporation | 2 | $49 |
Products named: REBLOZYL, DATROWAY, VENCLEXTA, EPKINLY, Enhertu, OJJAARA, ORGOVYX, IBRANCE.
Industry payments across AZ — which companies pay providers there.
